Title | Type | SJR | H index | Total Docs. (2019) | Total Docs. (3years) | Total Refs. (2019) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2019) | %Female (2019) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Frontiers in Pharmacology | journal | 1.228 Q1 | 154 | 1533 | 2951 | 98306 | 13190 | 2884 | 4.40 | 64.13 | 44.65 | |
2 | Advances in Therapy | journal | 0.979 Q1 | 83 | 276 | 516 | 10238 | 1926 | 497 | 3.82 | 37.09 | 37.99 | |
3 | Cardiology | journal | 0.559 Q2 | 72 | 128 | 347 | 2756 | 460 | 274 | 1.48 | 21.53 | 28.68 | |
4 | Inflammopharmacology | journal | 0.729 Q2 | 68 | 119 | 227 | 5767 | 728 | 223 | 3.16 | 48.46 | 44.48 | |
5 | Antibiotics | journal | 1.173 Q1 | 77 | 267 | 186 | 15719 | 790 | 183 | 4.34 | 58.87 | 44.22 | |
6 | Vaccines | journal | 1.743 Q1 | 85 | 213 | 180 | 14257 | 929 | 172 | 4.30 | 66.93 | 45.80 | |
7 | Chemotherapy | journal | 0.488 Q3 | 61 | 38 | 122 | 1076 | 209 | 119 | 1.71 | 28.32 | 40.20 | |
8 | Journal of Cardiovascular Development and Disease | journal | 32 | 37 | 118 | 2830 | 284 | 111 | 2.42 | 76.49 | 53.29 | ||
9 | Drugs - Real World Outcomes | journal | 0.559 Q2 | 21 | 22 | 90 | 773 | 175 | 89 | 1.68 | 35.14 | 36.36 | |
10 | PharmacoEconomics - Open | journal | 0.480 Q3 | 20 | 64 | 71 | 1806 | 97 | 62 | 1.37 | 28.22 | 41.79 | |
11 | Pharma-Kritik (discontinued) | journal | 0.107 Q4 | 2 | 13 | 59 | 167 | 3 | 41 | 0.05 | 12.85 | 40.00 | |
12 | EJNMMI Radiopharmacy and Chemistry | journal | 28 | 31 | 43 | 1482 | 124 | 38 | 2.27 | 47.81 | 33.53 | ||
13 | WHO Drug Information | journal | 0.126 Q4 | 11 | 11 | 32 | 89 | 17 | 29 | 0.17 | 8.09 | 50.00 | |
14 | Medical Cannabis and Cannabinoids | journal | 13 | 13 | 12 | 703 | 23 | 8 | 1.92 | 54.08 | 48.84 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®